Meeting Venue:
Hybrid –
Committee Room 3, Senedd
and video
conference via Zoom
Meeting date: 14 May 2025
Meeting time: 09.00
For further information contact:
Sarah Beasley
Committee Clerk
0300 200
6565
SeneddHealth@senedd.wales
<AI1>
Private
Pre-meeting
(9.00 -
9.30)
</AI1>
<AI2>
Public
meeting
(9.30 -
11.45)
</AI2>
<AI3>
1
Introductions, apologies, substitutions,
and declarations of interest
(09.30)
</AI3>
<AI4>
2
Ophthalmology Services in Wales -
evidence session - panel 5
(9.30-10.30)
(Pages 1 - 73)
Sam Hall, Director of Primary, Community and
Mental Health Digital Services, Digital Health and Care Wales
Helen Thomas, Chief Executive, Digital Health
and Care Wales
Dr Emma Cooke, Executive Director of Allied
Health Professionals, Health Scientists & Community Services
Development, Cardiff and Vale University Health Board
David Thomas, Director of Digital & Health
Intelligence, Cardiff and Vale University Health Board
Research brief
Paper 1 – Digital Health and Care
Wales
Paper 2 – Cardiff and Vale University
Health Board
</AI4>
<AI5>
Break
(10.30
-10.45)
</AI5>
<AI6>
3
Ophthalmology Services in Wales -
evidence session - panel 6
(10.45-11.45)
(Pages 74 - 109)
Carol Shillabeer, Chief Executive Officer,
Betsi Cadwaladr University Health Board.
Catherine Wood, Director of Operations for
Planned Care, Cardiff and Vale University Health Board.
Michael Stechman, Clinical Director for
Ophthalmology and Consultant General Surgeon, Cardiff and Vale
University Health Board.
Andrew Carruthers, Chief Operating Officer,
Hywel Dda University Health Board.
Paper 3 - Betsi Cadwaladr University Health
Board
Paper 4 - Cardiff and Vale University Health
Board
Paper 5 - Hywel Dda University Health
Board
</AI6>
<AI7>
4
Papers to note
(11.45)
</AI7>
<AI8>
4.1 Letter to Cabinet Secretary for Health and Social
Care requesting update on the actions being taken to improve
complaints handling by NHS Wales
(Page 110)
</AI8>
<AI9>
4.2 Reply from Cabinet Secretary for Health and Social
Care regarding actions to improve handling of complaints about NHS
Wales
(Pages 111 - 112)
</AI9>
<AI10>
4.3 Welsh Government's response to the Committee's report
on the Legislative Consent Memorandum for the Tobacco & Vapes
Bill
(Pages 113 - 121)
</AI10>
<AI11>
4.4 Letter from Tenovus Cancer Care regarding request to
hold a short inquiry into the implementation of the Committee's
report on gynaecological cancers
(Pages 122 - 123)
</AI11>
<AI12>
4.5 Letter to Tenovus Cancer Care regarding request to
hold a short inquiry into the implementation of the Committees'
report on gynaecological cancers
(Pages 124 - 125)
</AI12>
<AI13>
4.6 Letter from Tenovus Cancer care and Claire's
Campaign, regarding request for short inquiry into the
implementation oof the Committees' report on gynaecological
cancers
(Pages 126 - 131)
</AI13>
<AI14>
4.7 Letter from the Petitions Committee re petition:
P-06-1435: We’re calling on the Welsh Government to commit to
implementing targeted lung cancer screening
(Pages 132 - 133)
</AI14>
<AI15>
4.8 Letter from the Minister for Children and Social Care
in response to stage one scrutiny report on the Health and Social
Care (Wales) Bill and recommendations associated with the
eliminating profit provisions contained within the
legislation
(Pages 134 - 137)
</AI15>
<AI16>
4.9 Letter to Welsh Local Government Association
requesting information to inform the inquiry into prevention
of ill health –obesity
(Pages 138 - 140)
</AI16>
<AI17>
4.10 Reply
from Welsh Local Government Association providing information to
inform the inquiry into prevention of ill health-
obesity
(Pages 141 - 163)
</AI17>
<AI18>
4.11 Letter from the Minister for Children and Social Care
in response to Health and Social Care (Wales) Bill report,
recommendation 9, on the progress being made with the transition to
a not-for-profit model
(Pages 164 - 187)
</AI18>
<AI19>
4.12 Letter to NHS Wales Chief Executive regarding the NHS
Executive Strategic Clinical Network for Diabetes
(Pages 188 - 189)
</AI19>
<AI20>
4.13 Reply
from the NHS Wales Chief Executive regarding the NHS
Executive Strategic Clinical Network for Diabetes
(Pages 190 - 191)
</AI20>
<AI21>
5
Motion under Standing Order 17.42 (ix) to
resolve to exclude the public from the remainder of this
meeting
(11.45)
</AI21>
<AI22>
Private
meeting
(11.45-12.00)
</AI22>
<AI23>
6
Ophthalmology Services in Wales:
consideration of evidence
(11.45-12.00)
</AI23>
<TRAILER_SECTION>
</TRAILER_SECTION>
<LAYOUT_SECTION>
1.
FIELD_TITLE
FIELD_FOOTNOTE
F_PR
FIELD_SUMMARY
</LAYOUT_SECTION>
<TITLE_ONLY_LAYOUT_SECTION>
2.
FIELD_TITLE
FIELD_FOOTNOTE
F_PR
</TITLE_ONLY_LAYOUT_SECTION>
<HEADING_LAYOUT_SECTION>
FIELD_TITLE
FIELD_FOOTNOTE
</HEADING_LAYOUT_SECTION>
<TITLED_COMMENT_LAYOUT_SECTION>
FIELD_TITLE
FIELD_FOOTNOTE
FIELD_SUMMARY
</TITLED_COMMENT_LAYOUT_SECTION>
<COMMENT_LAYOUT_SECTION>
FIELD_SUMMARY
</COMMENT_LAYOUT_SECTION>
<SUBNUMBER_LAYOUT_SECTION>
2.1.
FIELD_TITLE
FIELD_FOOTNOTE
F_PR
FIELD_SUMMARY
</SUBNUMBER_LAYOUT_SECTION>
<TITLE_ONLY_SUBNUMBER_LAYOUT_SECTION>
2.2.
FIELD_TITLE
FIELD_FOOTNOTE
F_PR
</TITLE_ONLY_SUBNUMBER_LAYOUT_SECTION>